Skip to main content
Fig. 1 | The Journal of Headache and Pain

Fig. 1

From: The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study

Fig. 1

Change in days with (a) headache, (b) migraine, and (c) medication use in patients with CM by MO. Values shown are the mean changes from baseline in the monthly average number of (a) headache days of at least moderate severity, (b) migraine days, and (c) acute headache medication use during the 12-week treatment period with and without MO. CM, chronic migraine; LSM, least-squares mean; MO, medication overuse; SE, standard error

Back to article page